Reporting of Respiratory Virus-Associated Pediatric Mortalities
November 16, 2026
Dear Colleague:
Every year, respiratory viruses like influenza (flu), SARS-CoV-2 (COVID-19), and respiratory syncytial virus (RSV) lead to a significant number of hospitalizations and deaths. It is important to quantify and understand the burden and nature of severe outcomes from these respiratory viruses, especially in pediatric populations in Virginia. These public health surveillance efforts can help us better understand which populations may be at higher risk of severe outcomes and can ultimately inform prevention strategies.
Beginning October 26, 2026, the Virginia Department of Health (VDH) requests that physicians (including medical examiners) and persons in charge of a medical facility voluntarily report deaths in individuals less than 18 years of age following an illness clinically compatible with COVID-19 or RSV infection. This request for voluntary reporting is being conducted in accordance with the authority outlined in the Virginia Regulations for Disease Reporting and Control, 12 VAC 5-90-80, Section H. These deaths can be reported to your local health department through normal disease reporting processes.
Influenza-associated pediatric mortality has been reportable in Virginia since 2007, and there are no changes to reporting of this condition.
Respiratory illness activity in Virginia is currently low but is trending up. Please continue to encourage your patients and healthcare colleagues to be up to date on recommended respiratory virus immunizations. It is not too late to receive the seasonal flu vaccine, which is recommended for all people over six months of age. COVID-19 vaccines are available for everyone aged six months and older and are especially recommended for those at high risk of severe disease, including older adults, infants, and during pregnancy. RSV immunizations help protect older adults, infants (via maternal RSV vaccination or infant immunization with RSV monoclonal antibody), and young children from severe RSV disease.
Please visit the Respiratory Diseases in Virginia webpage for additional resources and data products. Specific information is available to address Preventing Transmission of Respiratory Viruses in Healthcare Settings.
Thank you for your continued partnership in keeping Virginians safe from respiratory illnesses.
Sincerely,
B. Cameron Webb, MD, JD
State Health Commissioner


